[1]
Arnulf I., Zeitzer J.M., File J., et al.: Kleine-Levin syndrome: a systematic
review of 186 cases in the literature. Brain 2005: 128: 2763-2776.
[2]
American Academy of Sleep Medicine., The international classification
of sleep disorders: diagnostic and coding manual 3 rd ed. 2nd ed. 2014,
Chicago: American Academy of Sleep Medicine. xviii, 297 p.
[3]
Arnulf I., Rico T.J., E. Mignot E.: Diagnosis, disease course, and
management of patients with Kleine-Levin syndrome. Lancet Neurol
2012: 11: 918-928.
[4]
Arnulf I., Lin L., Gadoth N., et al.: Kleine-Levin syndrome: a systematic
study of 108 patients. Ann Neurol 2008: 63: 482-493.
[5]
Billiard M., Jaussent I., Dauvilliers Y., et al.: Recurrent hypersomnia:
a review of 339 cases. Sleep Med Rev 2011; 15: 247-257.
[6]
Lavault S., Golmard J.L., Groos E., et al.: Kleine-Levin syndrome in 120
patients: differential diagnosis and long episodes. Ann Neurol 2015; 77:
529-540.
[7]
Gadoth N., Kesler A., VainsteinG., et al.: Clinical and polysomnographic
characteristics of 34 patients with Kleine-Levin syndrome. J Sleep Res
2001; 10: 337-341.
[8]
Dauvilliers Y., Mayer G., Lecendreux M., et al.: Kleine-Levin syndrome:
an autoimmune hypothesis based on clinical and genetic analyses.
Neurology 2002; 59: 1739-1745.
[9]
Al Shareef S.M., Basit S., Li S., et al.: Kleine-Levin syndrome is associated
with LMOD3 variants. J Sleep Res 2019; 28: e12718.
[10]
Mehdi T.: Kleine-Levin syndrome is associated with LMOD3 variants.
J Sleep Res, 2020; 29: e12849.
[11]
Kas A., Lavault S., Habert M. O., et al.: Feeling unreal: a functional
imaging study in patients with Kleine-Levin syndrome. Brain 2014; 137:
2077-2087.
[12]
Billiard M., Guilleminault C., Dement W.C.,: A menstruation-linked
periodic hypersomnia. Kleine-Levin syndrome or new clinical entity?
Neurology 1975; 25: 436-443.
[13]
de Oliveira M.M., Conti C., Prado G.F.: Pharmacological treatment for
Kleine-Levin syndrome. Cochrane Database Syst Rev 2016;(5): p.
CD006685.
[14]
Hart E.J.: Kleine-Levin syndrome: normal CSF monoamines and response
to lithium therapy. Neurology 1985; 35: 1395-1396.
[15]
Leu-Semenescu S., Le Corvec T., Groos E., et al.: Lithium therapy in
Kleine-Levin syndrome: An open-label, controlled study in 130 patients.
Neurology 2015; 85: 1655-1662.
[16]
Loganathan S., Manjunath S., Jhirwal O.M., et al.: Lithium prophylaxis in
Kleine-Levin syndrome. J Neuropsychiatry Clin Neurosci 2009; 21: 107-
108.
[17]
Muratori F., Bertini N., Masi G.: Efficacy of lithium treatment in Kleine-
Levin syndrome. Eur Psychiatry 2002; 17: 232-233.
[18]
Mukaddes N.M., Kora M. E., Bilge S.: Carbamazepine for Kleine-Levin
syndrome. J Am Acad Child Adolesc Psychiatry 1999; 38: 791-792.
[19]
Savet J.F., Robert H., Angeli C.: [A case of Kleine-Levin syndrome stabilized
for over 1 year with carbamazepine]. Presse Med 1986; 15: 1281.
[20]
Mignot E.J.: A practical guide to the therapy of narcolepsy and
hypersomnia syndromes. Neurotherapeutics 2012; 9: 739-752.
[21]
Gallinek A.,: The Kleine-Levin syndrome: hypersomnia, bulimia, and
abnormal mental states. World Neurol 1962; 3: 235-243.
Scholar Google
PubMed